MedCity NewsCAR T-cell therapy shows promise for patients with myelomaHealioChimeric antigen receptor (CAR) T-cell therapies have demonstrated success in targeting B-cell biomarkers in clinical trials for acute lymphoblastic leukemia and lymphoma. Howe… Continue reading
Penn State News |
Two-part system turns stem cells into whatever you want
Penn State News UNIVERSITY PARK, Pa. — Whether using embryonic or adult stem cells, coercing these master cells to convert to the desired target cell and reproduce flawlessly is difficult. Now an international team of researchers has a two-part system that can … |
STAT |
A first: All respond to CAR–T therapy in a blood cancer study
STAT HICAGO — Doctors are reporting unprecedented success from a new cell and gene therapy for multiple myeloma, a blood cancer that’s on the rise. Although it’s early and the study is small — 35 people — every patient responded and all but two were in … CAR T- Cell Therapy Could Be A Promising Treatment For Multiple Myeloma CancerScience World Report Therapy Shows High Remission Rates in Multiple MyelomaCuretoday.com Gene-Based Therapy That Reprograms Immune Cells Offers Hope For Multiple Myeloma CureTech Times WBOC TV 16 all 18 news articles » |
Science Daily |
CRISPR tech leads to new screening tool for Parkinson’s disease
Science Daily They are using CRISPR Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) gene-editing technology. The system is one of research’s fastest growing biomedical techniques that allows scientists to make specific changes in the DNA of plants … |
FierceBiotech |
CAR T-Cell therapy sends multiple myeloma into lasting remission
Science Daily CAR T-cell therapy is custom-made for each patient. The patient’s own T cells are collected, genetically reprogrammed in a lab, and injected back into the patient. The reprogramming involves inserting an artificially designed gene into the T-cell … CAR T-cell therapy shows promise for patients with myelomaHealio ASCO dark horse Nanjing Legend Biotech shines with promising CAR–T dataFierceBiotech Bluebird is pretty chirpy about its anti-BCMA CAR–T therapy resultsMedCity News TheStreet.com –Reuters –Business Wire (press release) all 14 news articles » |